SKAN Research Trust (SKAN), promoted by Indian entrepreneur Ashok Soota, today announced a joint research project …
Groundbreaking New Blood Test Offers Early Pancreatic Cancer Diagnosis Study Says
As reported in today’s issue of the journal Metabolites, researchers at Metabolomycs, a California-based biotechnology company, for the …
Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation …
K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer
K36 Therapeutics, Inc. (“K36”), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor …
Genetics of Nearby Healthy Tissue May Help Catch Lung Cancer’s Return
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor …
Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with AI Expertise
Deep Bio, a leading AI healthcare company specializing in deep learning and cancer pathology, is …
Oncoclínicas opens first Cancer Center in Brazil as an International Collaborative Member of Dana-Farber Cancer Institute
Oncoclínicas&Co, the largest group dedicated to cancer in Latin America, and Dana-Farber Cancer Institute, a Harvard Medical …
Prostate Cancer Diagnosis Just Got Easier with CE Mark Certification of Lucida Medical’s New AI Software
Lucida Medical Ltd, a Cambridge-based start-up company dedicated to improving cancer diagnosis, has announced Class IIb CE …
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for …
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new …
